FDA Person
FDAMichael Serrano
View detailed information about Michael Serrano, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 130 inspections of 114 companies, 2016–2026.
Inspections (130)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 25, 2026 | Janssen Pharmaceuticals, Inc | VAI | Postmarket Surv. and Epidemiology | #1338168 |
| September 3, 2026 | Impulse Dynamics (USA), Inc. | Not classified | #1336660 | |
| August 19, 2026 | GSK LLC (GlaxoSmithKline) | Not classified | #1318026 | |
| July 24, 2026 | SUN PHARMACEUTICAL INDUSTRIES INC | Not classified | Bioresearch Monitoring | #1328400 |
| June 11, 2026 | Qing Wen | Not classified | #1324516 | |
| June 4, 2026 | Guomin Xiao | Not classified | #1323466 | |
| May 20, 2026 | Elevar Therapeutics, Inc. | Not classified | Bioresearch Monitoring | #1318414 |
| April 28, 2026 | Bristol Myers Squibb | Not classified | #1316958 | |
| March 30, 2026 | Clinilabs, LLC | Not classified | #1312114 | |
| March 10, 2026 | Acadia Pharmaceuticals Inc. | Not classified | #1309598 | |
| January 28, 2026 | Kevin Ma | Not classified | #1302586 | |
| December 12, 2025 | Bristol-Myers Squibb Company | Not classified | #1299176 | |
| November 6, 2025 | BeOne Medicines USA, Inc. | NAI | Bioresearch Monitoring | #1293402 |
| October 28, 2025 | Vinay Sikand, M.D. | Not classified | #1290456 | |
| September 19, 2025 | Verity Pharmaceuticals Inc. | Not classified | #1283942 | |
| September 19, 2025 | Verity Pharmaceuticals Inc. | NAI | Bioresearch Monitoring | #1283942 |
| September 10, 2025 | Fox Chase Cancer Center IRB | NAI | Bioresearch Monitoring | #1283950 |
| August 26, 2025 | Prinston Pharmaceutical Inc | Not classified | #1260044 | |
| July 25, 2025 | Jinhai Zhu | NAI | Bioresearch Monitoring | #1279024 |
| July 18, 2025 | Yu Ren, M.D., Ph.D. | NAI | Bioresearch Monitoring | #1279041 |
Documents (61)
- EIR · Rho, Inc. · June 30, 2017
- EIR · Ranbaxy Inc. · June 20, 2017
- 483 · Englewood Hospital and Medical Center IRB · November 26, 2019
- EIR · John L. Berk, M.D. · June 21, 2018
- 483 · Wissam Abouzgheib, MD · January 29, 2018
- 483 · SK Life Science Inc. · August 11, 2021
- 483 · Nationwide Laboratories, LLC · November 27, 2018
- EIR · Amerigen Pharmaceuticals Inc. · January 18, 2019
- 483 · St. Peter's University Hospital - CPHSR · February 8, 2019
- EIR · Allergan · April 11, 2019
- 483 · Dipakkumar P. Pandya, M.D. · February 1, 2024
- 483 · Tris Pharma Inc. · March 8, 2024
- EIR · Actavis Elizabeth LLC, A Company of Teva · April 26, 2011
- 483 · Merck & Co. Inc · November 19, 2015
- 483 · Bausch Health US., LLC. · November 7, 2024
- 483 · Insmed Incorporated · April 3, 2025
- EIR · Bristol Myers Squibb · February 2, 2022
- 483 · Ida Vanessa Doederlein Schwartz, MD · January 31, 2025
- 483 · Alvogen, Inc · June 10, 2021
- 483 · Robert Wood Johnson U Hosp @ Hamilton IRB · December 22, 2021
- 483 · Ahsan A. Abdulghani, M.D. · August 21, 2023
- EIR · SK Life Science Inc. · August 11, 2021
- 483 · Carlos Lastra MD · January 13, 2020
- 483 · Allergan, PLC. · April 11, 2019
- 483 · Merck & Co. Inc · August 26, 2016
- 483 · Teva Pharmaceuticals USA, Inc · September 29, 2023
- EIR · Leading Pharma, LLC · August 11, 2020
- 483 · Alvogen, Inc · September 11, 2020
- 483 · Eugenia Girda, MD · October 18, 2022
- 483 · St. Peter's University Hospital - CPHSR · July 4, 2019
- EIR · Mitsubishi Tanabe Pharma Development America, Inc. · October 15, 2021
- EIR · John L. Berk, M.D. · July 22, 2021
- 483 · Deborah A. Goss, M.D. · March 17, 2025
- EIR · Clario (BioClinica, Inc.) · September 26, 2019
- 483 · Vinay Sikand, M.D. · September 14, 2023
- EIR · Covance Laboratories Inc. · July 26, 2017
- 483 · Navinta, LLC · March 28, 2019
- 483 · Colgate-Palmolive Company · May 30, 2019
- 483 · Fresenius Medical Care Holdings, Inc. · August 2, 2019
- 483 · Stephen S. Kasparian, MD · September 2, 2021
- 483 · Steven David, M.D. · January 8, 2018
- EIR · APCER Life Sciences, Inc. · June 21, 2016
- EIR · Janssen Pharmaceuticals Inc. · January 22, 2016
- 483 · Larken Laboratories, Inc. · October 8, 2020
- 483 · Sanofi US · August 3, 2016
- 483 · RISING PHARMACEUTICALS INC · January 28, 2019
- 483 · Quagen Pharmaceuticals LLC · November 8, 2023
- EIR · Bristol-Myers Squibb Company · June 27, 2018
- 483 · Actavis Elizabeth LLC, A Company of Teva · April 26, 2011
- 483 · Bausch Health US., LLC. · June 16, 2021
- 483 · Robert S. Falcone, M.D. · April 5, 2021
- EIR · Clario Inc · January 10, 2022
- 483 · Ascend Laboratories, LLC · November 10, 2021
- 483 · Nikolaos T. Pyrsopoulos, M.D. · February 22, 2022
- 483 · Rho, Inc. · June 30, 2017
- EIR · Catalent Pharma Solutions, LLC · July 13, 2018
- 483 · Dr. Reddy's Laboratories, Inc. · May 26, 2022
- EIR · Wissam Abouzgheib, MD · January 29, 2018
- 483 · Mitsubishi Tanabe Pharma Development America, Inc. · October 15, 2021
- 483 · Elevar Therapeutics, Inc. · May 20, 2026
- 483 · SUN PHARMACEUTICAL INDUSTRIES INC · July 24, 2026
Frequently inspected with (10)
Person Information
Name
Michael Serrano
Title
investigator
Role
COMPANY REP
ID: 44c9d307-9d78-4480-b1d0-36096c056642
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.